[{"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-001", "question": "A 39-year-old man presents with recurrent pancreatitis and is found to have a 2.5-cm enhancing mass in the pancreatic head that encases the intrapancreatic common bile duct, with upstream dilatation but no vascular involvement. EUS-FNA is nondiagnostic twice. CA 19-9 is normal. IgG4 level is mildly elevated at 180 mg/dL (ULN 135). CT shows a capsule-like rim around the lesion and diffuse, sausage-shaped enlargement of the gland. Which management approach is most appropriate?", "options": ["Trial of high-dose corticosteroids with close radiologic follow-up before considering surgery", "Pancreaticoduodenectomy because focal autoimmune pancreatitis cannot be reliably distinguished from adenocarcinoma", "Repeat EUS-FNA with core needle and flow cytometry to exclude lymphoma", "Observation alone with serial imaging in 6 months given low CA 19-9 and mild symptoms", "ERCP with biliary brushing cytology and stent placement, with surgery only if cytology is positive"], "answer": "A", "answer_index": 0, "explanation": "Imaging findings (capsule-like rim, sausage-shaped gland) and elevated IgG4 strongly suggest type 1 autoimmune pancreatitis; a steroid trial with close monitoring is accepted to avoid unnecessary Whipple when malignancy is not strongly supported. Immediate pancreaticoduodenectomy (B) is premature. Repeat biopsy (C) is less helpful given characteristic features. Observation alone (D) ignores ongoing pancreatitis and biliary obstruction. ERCP cytology (E) has low sensitivity and does not treat underlying inflammatory disease.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "abms_specialty": "Gastrointestinal", "abms_source": "target_topic", "source_label_raw": "Gastrointestinal", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed130.jsonl", "pred": "A", "model_outputs": "Let me analyze this case systematically.\n\nKey Clinical Features:\n- 39-year-old man with recurrent pancreatitis\n- 2.5-cm enhancing mass in pancreatic head\n- Encases intrapancreatic common bile duct with upstream dilatation\n- No vascular involvement\n- EUS-FNA nondiagnostic twice\n- CA 19-9 normal\n- IgG4 mildly elevated (180 mg/dL, ULN 135)\n- CT shows capsule-like rim around lesion\n- Diffuse, sausage-shaped enlargement of the gland\n\nAnalysis:\n\nThis presentation is highly suggestive of Type 1 Autoimmune Pancreatitis (AIP)/IgG4-related disease:\n- Sausage-shaped pancreas (classic finding)\n- Capsule-like rim (characteristic of AIP)\n- Elevated IgG4 (though only mildly - >2x ULN is more specific)\n- Normal CA 19-9\n- Younger patient (pancreatic adenocarcinoma typically presents older)\n\nEvaluating Options:\n\nA. Trial of high-dose corticosteroids with close radiologic follow-up - This is the standard approach for suspected AIP. The International Consensus Diagnostic Criteria for AIP support a steroid trial when imaging is highly suggestive but histology is unavailable. Response to steroids is both diagnostic and therapeutic.\n\nB. Pancreaticoduodenectomy - While distinguishing AIP from adenocarcinoma can be challenging, proceeding directly to major surgery without a steroid trial in a case with classic AIP features would be inappropriate.\n\nC. Repeat EUS-FNA for lymphoma - Lymphoma is not the primary concern here given the classic AIP imaging features.\n\nD. Observation alone - This would be inappropriate given biliary obstruction and recurrent pancreatitis.\n\nE. ERCP with brushing - While ERCP might help with biliary obstruction, brushings have low sensitivity, and this doesn't address the underlying diagnosis.\n\nThe imaging findings (sausage-shaped pancreas, capsule-like rim) combined with elevated IgG4 strongly suggest AIP. Per guidelines, a steroid trial with close follow-up is appropriate when clinical/radiological features are highly suggestive of AIP but tissue diagnosis is not obtained.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-002", "question": "A 72-year-old man with long-standing COPD (FEV1 35% predicted), chronic hypercapnia, and recent admission for an acute exacerbation requiring noninvasive ventilation is evaluated 3 weeks after discharge. He continues to have daytime somnolence and morning headaches despite resolution of wheeze and normalization of oxygenation on 2 L/min nasal cannula. ABG on his usual oxygen shows pH 7.37, PaCO2 58 mm Hg, PaO2 70 mm Hg, HCO3- 33 mEq/L. Overnight oximetry reveals sustained hypoventilation with episodic desaturations but no significant obstructive apneas. He is adherent to inhaled therapy and pulmonary rehab. What is the most appropriate next step in chronic management to improve mortality?", "options": ["Increase long-term oxygen therapy to maintain PaO2 >80 mm Hg", "Start nocturnal noninvasive ventilation with targeted normalization of PaCO2", "Add chronic low-dose oral prednisone", "Begin acetazolamide at night to stimulate ventilation", "Switch to high-flow nasal cannula at home during sleep"], "answer": "B", "answer_index": 1, "explanation": "In stable COPD with chronic hypercapnic respiratory failure, particularly after a hypercapnic exacerbation, nocturnal noninvasive ventilation targeting PaCO2 reduction reduces mortality and hospitalizations. Increasing oxygen can worsen hypercapnia; chronic steroids confer harm; acetazolamide has limited long-term data; home high-flow therapy improves comfort but lacks robust mortality benefit compared with NIV in this phenotype.", "generator_model": "gpt-5.1-2025-11-13", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pulmonary", "abms_specialty": "Pulmonary", "abms_source": "topics_mapped", "source_label_raw": "pulmonology", "source_quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed123", "source_question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed123-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251129T045001943Z_gpt-5.1-2025-11-13_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T045001943Z_gpt-5.1-2025-11-13_seed123.jsonl", "pred": "B", "model_outputs": "Let me analyze this case systematically.\n\nPatient Profile:\n- 72-year-old man with severe COPD (FEV1 35% predicted)\n- Chronic hypercapnia (compensated respiratory acidosis: pH 7.37, PaCO2 58, HCO3- 33)\n- Recent acute exacerbation requiring NIV\n- Persistent symptoms: daytime somnolence, morning headaches\n- Overnight oximetry shows sustained hypoventilation with episodic desaturations (no significant OSA)\n- Adherent to optimal medical therapy\n\nKey Clinical Features:\nThe morning headaches and daytime somnolence despite adequate oxygenation suggest nocturnal hypoventilation with CO2 retention. The overnight oximetry confirms hypoventilation pattern.\n\nAnalyzing Options:\n\nA. Increase LTOT to maintain PaO2 >80 mm Hg\n- His PaO2 is already 70 mm Hg on 2L, which is adequate\n- Increasing oxygen in a chronic hypercapnic patient could worsen CO2 retention\n- No mortality benefit shown for targeting higher PaO2\n\nB. Start nocturnal NIV with targeted normalization of PaCO2\n- The HOT-HMV trial and other studies have shown that domiciliary NIV in stable hypercapnic COPD patients (especially post-exacerbation with persistent hypercapnia) improves mortality and reduces readmissions\n- Key is targeting reduction of PaCO2 (high-intensity NIV approach)\n- Addresses the underlying nocturnal hypoventilation causing his symptoms\n\nC. Add chronic low-dose oral prednisone\n- Not recommended for stable COPD\n- Associated with significant side effects without mortality benefit\n\nD. Begin acetazolamide at night\n- Can stimulate ventilation but evidence is limited\n- Not standard of care for chronic hypercapnic COPD\n- No proven mortality benefit\n\nE. Switch to high-flow nasal cannula during sleep\n- Less effective than NIV for hypercapnic respiratory failure\n- Does not provide the ventilatory support needed for significant hypoventilation\n\nConclusion:\nThis patient has persistent hypercapnia (PaCO2 58) 3 weeks post-exacerbation with symptoms of nocturnal hypoventilation. The HOT-HMV trial demonstrated that home NIV added to home oxygen therapy in patients with persistent hypercapnia following an acute exacerbation significantly reduces mortality and hospital readmissions.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-003", "question": "A 55-year-old man from a region endemic for Lyme disease presents with 1 week of rapidly progressive bilateral leg weakness and numbness ascending from the feet, severe radicular pain, and new urinary retention. He was treated with oral doxycycline 3 weeks ago for erythema migrans following a hiking trip. Exam: symmetric lower extremity weakness 3/5 proximally and distally, hyperreflexia with bilateral Babinski signs, decreased pinprick below T10, preserved vibration sense in toes, and saddle hypesthesia. Cranial nerves are normal. MRI spine with contrast: multifocal enhancing lesions in the thoracic cord with associated leptomeningeal enhancement; no compressive lesion. CSF: WBC 220/µL (80% lymphocytes), protein 120 mg/dL, glucose 45 mg/dL (serum 90), oligoclonal bands present; CSF Lyme antibody index is elevated. HIV, syphilis, and TB tests are negative. What is the most appropriate treatment?", "options": ["High-dose IV methylprednisolone alone for presumed idiopathic transverse myelitis", "IV ceftriaxone 2 g daily for 4 weeks without steroids", "IV ceftriaxone 2 g daily plus high-dose IV methylprednisolone", "Oral doxycycline 100 mg BID for 28 days plus high-dose oral prednisone taper", "Plasma exchange for 5-7 sessions followed by IV ceftriaxone"], "answer": "B", "answer_index": 1, "explanation": "This is Lyme neuroborreliosis with meningomyelitis confirmed by elevated CSF Lyme antibody index and appropriate clinical picture; standard treatment is prolonged IV ceftriaxone without routine adjunctive steroids. Steroids alone (A) are inappropriate and may worsen infection. Adding high-dose steroids to antibiotics (C) has no proven benefit and may be harmful. Oral doxycycline (D) is inadequate for CNS parenchymal involvement. Plasma exchange (E) is used in severe autoimmune demyelination (e.g., NMO, ADEM) and is not indicated here once Lyme is confirmed.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "abms_specialty": "Infectious Disease", "abms_source": "topics_mapped", "source_label_raw": "Infectious Disease", "source_quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "source_question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-009", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T045001943Z_gpt-5.1-2025-11-13_seed124.jsonl", "pred": "C", "model_outputs": "Let me analyze this case systematically.\n\nClinical Presentation:\n- 55-year-old man from Lyme-endemic area\n- History of erythema migrans treated with oral doxycycline 3 weeks ago\n- Rapidly progressive bilateral leg weakness, numbness ascending from feet\n- Severe radicular pain, urinary retention\n- Exam: symmetric weakness, hyperreflexia, bilateral Babinski signs, sensory level at T10, saddle hypesthesia\n\nKey Findings:\n- MRI: multifocal enhancing thoracic cord lesions with leptomeningeal enhancement\n- CSF: lymphocytic pleocytosis (220 WBC, 80% lymphocytes), elevated protein (120), low glucose (45 with serum 90), oligoclonal bands present\n- Elevated CSF Lyme antibody index - this is diagnostic of CNS Lyme disease (neuroborreliosis)\n- HIV, syphilis, TB negative\n\nDiagnosis: This is Lyme myelitis/neuroborreliosis with myelopathy. The elevated CSF Lyme antibody index confirms active CNS Lyme infection. The initial oral doxycycline treatment was inadequate for preventing CNS involvement.\n\nTreatment Considerations:\n\n1. IV Ceftriaxone is the standard treatment for neuroborreliosis (CNS Lyme disease) - it penetrates the blood-brain barrier well. The typical regimen is 2g IV daily for 2-4 weeks.\n\n2. Oral doxycycline (Option D) is NOT adequate for CNS Lyme disease due to poor CNS penetration.\n\n3. Corticosteroids: In cases of Lyme myelitis with significant inflammation (as evidenced by enhancing lesions, leptomeningeal enhancement, and marked CSF pleocytosis), adjunctive corticosteroids are often recommended to reduce inflammation and prevent permanent neurological damage. This is similar to the approach in other inflammatory myelopathies.\n\n4. Steroids alone (Option A) would be inappropriate as this is an infectious etiology requiring antimicrobial treatment.\n\n5. Plasma exchange (Option E) is typically reserved for severe demyelinating conditions unresponsive to steroids, not first-line for Lyme myelitis.\n\nBest Answer: Given the severity of presentation (rapidly progressive myelopathy with significant inflammation), the combination of IV ceftriaxone (to treat the infection) plus IV methylprednisolone (to reduce inflammation and prevent cord damage) is the most appropriate approach.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-004", "question": "A 4-year-old girl with newly diagnosed steroid-sensitive nephrotic syndrome starts high-dose prednisone 2 mg/kg/day. Baseline blood pressure and renal function were normal. After 3 weeks she achieves complete remission of proteinuria, but blood pressure is now consistently at the 98th percentile systolic and 99th percentile diastolic for age/height. Labs: normal electrolytes, creatinine 0.3 mg/dL, albumin 3.5 g/dL, and a normal echocardiogram. She has no headaches or visual changes. Which of the following is the most appropriate next step in management of her hypertension?", "options": ["Initiate an ACE inhibitor and maintain the current steroid dose until 6 weeks are completed", "Switch from daily to alternate-day prednisone dosing immediately and start a calcium channel blocker", "Begin a low-dose thiazide diuretic while continuing full-dose prednisone and sodium restriction", "Add tacrolimus and rapidly taper prednisone over 5 days while observing blood pressure", "Discontinue prednisone abruptly and monitor for adrenal insufficiency while starting an ARB"], "answer": "B", "answer_index": 1, "explanation": "In steroid-sensitive nephrotic syndrome with early remission and steroid-induced hypertension, the recommended approach is early transition to alternate-day prednisone while treating hypertension with an agent such as a calcium channel blocker; this reduces steroid toxicity without compromising remission. Abrupt discontinuation risks disease relapse and adrenal suppression, and ACEi/ARB are less favored for primary BP control with normal renal function and no persistent proteinuria.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed128.jsonl", "pred": "B", "model_outputs": "Let me analyze this case systematically.\n\nPatient Profile:\n- 4-year-old girl with steroid-sensitive nephrotic syndrome\n- On high-dose prednisone (2 mg/kg/day) for 3 weeks\n- Achieved complete remission (proteinuria resolved)\n- Now has significant hypertension (98th/99th percentile)\n- Normal labs, normal echo, asymptomatic\n\nKey Considerations:\n\n1. Steroid-induced hypertension: This is a well-known side effect of high-dose corticosteroids, occurring through mineralocorticoid effects and other mechanisms.\n\n2. Standard treatment protocol for steroid-sensitive nephrotic syndrome: Typically involves daily high-dose prednisone for 4-6 weeks, then transition to alternate-day dosing with gradual taper.\n\n3. The hypertension is significant (>95th percentile) but she's asymptomatic with normal echo, so it's not a hypertensive emergency.\n\nAnalyzing Options:\n\nA. ACE inhibitor + maintain current dose until 6 weeks - ACE inhibitors are often first-line for nephrotic syndrome-related hypertension, but continuing full-dose steroids when remission is achieved at 3 weeks may not be necessary.\n\nB. Switch to alternate-day dosing + calcium channel blocker - This addresses the steroid-induced hypertension by reducing steroid exposure (switching to alternate-day is appropriate after achieving remission) and adds antihypertensive therapy.\n\nC. Thiazide + continue full-dose prednisone + sodium restriction - Thiazides aren't first-line for steroid-induced hypertension, and continuing full-dose steroids isn't optimal.\n\nD. Add tacrolimus + rapid taper - This is inappropriate; tacrolimus is for steroid-resistant or frequently relapsing cases, and rapid taper is dangerous.\n\nE. Discontinue prednisone abruptly - This risks adrenal crisis and nephrotic syndrome relapse; never appropriate.\n\nBest Answer:\nSince the patient has achieved complete remission at 3 weeks, transitioning to alternate-day dosing is appropriate per standard protocols (this reduces steroid side effects including hypertension). Adding a calcium channel blocker (like amlodipine) is reasonable for managing the hypertension while the steroid effects diminish.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-005", "question": "A 28-year-old man is brought to the ED after a high-speed MVC with hypotension and abdominal distension. FAST is positive in Morrison's pouch and pelvis. He undergoes emergent laparotomy with splenectomy and packing of diffuse hepatic oozing. Postoperatively in the ICU, he remains hypotensive despite 6 units PRBC, 6 units FFP, and 1 apheresis platelet unit. Core temperature is 33.5°C, pH 7.09, ionized calcium 0.9 mmol/L, and INR 2.4. Oozing continues from surgical drains. Which of the following is the next best step in management of his ongoing bleeding?", "options": ["Administer recombinant factor VIIa to promote thrombin generation", "Provide additional FFP and platelets guided by clinical judgment", "Initiate aggressive rewarming, calcium replacement, and correction of acidosis before further factor therapy", "Begin a continuous IV heparin infusion to treat consumptive coagulopathy", "Administer desmopressin to improve platelet adhesion"], "answer": "C", "answer_index": 2, "explanation": "This patient has the lethal triad of hypothermia, acidosis, and coagulopathy in massive trauma; correcting temperature, acidosis, and ionized calcium is crucial for coagulation to work and should precede or accompany further factor replacement. Recombinant factor VIIa is less effective and risky in this physiologic state, and empiric heparin or DDAVP will not address the fundamental problem.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "target_topic", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed128.jsonl", "pred": "C", "model_outputs": "This patient is presenting with the \"lethal triad\" of trauma: hypothermia (33.5°C), acidosis (pH 7.09), and coagulopathy (INR 2.4). He also has hypocalcemia (ionized calcium 0.9 mmol/L), which is critical for the coagulation cascade.\n\nLet me analyze each option:\n\nA. Recombinant factor VIIa - While this can promote thrombin generation, it will not work effectively in the setting of hypothermia, acidosis, and hypocalcemia. Coagulation factors function poorly under these conditions.\n\nB. Additional FFP and platelets guided by clinical judgment - More clotting factors won't help if the physiological environment doesn't allow them to function properly. The enzymes in the coagulation cascade are temperature and pH dependent.\n\nC. Aggressive rewarming, calcium replacement, and correction of acidosis - This addresses the fundamental problem. Coagulation enzymes work optimally at normal body temperature and pH. Calcium is essential as a cofactor in multiple steps of the coagulation cascade. Without correcting these physiological derangements, no amount of blood products will effectively stop the bleeding.\n\nD. Heparin infusion - This would be contraindicated in a patient who is actively bleeding. While DIC can occur in trauma, anticoagulation is not appropriate in this hemorrhaging patient.\n\nE. Desmopressin - This can help with platelet adhesion by releasing von Willebrand factor, but it won't address the underlying physiological derangements preventing normal coagulation.\n\nThe key principle in trauma-induced coagulopathy is that you must correct the physiological derangements (hypothermia, acidosis, hypocalcemia) for coagulation factors to function. This is the concept behind \"damage control resuscitation.\" The coagulation cascade enzymes are temperature-sensitive and pH-sensitive, and calcium is required as a cofactor.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-006", "question": "A 28-year-old G1P0 woman at 33 weeks' gestation presents to the ED with acute dyspnea, pleuritic chest pain, and near syncope. HR 132/min, BP 82/48 mm Hg, RR 30/min, SpO2 89% on 6 L nasal cannula. Bedside echo reveals a dilated RV with McConnell sign and septal flattening. CTA is unavailable; lower-extremity duplex is pending. She is consentable and has no contraindications to thrombolysis. Fetal heart tones are 150 bpm with moderate variability. Which management is most appropriate now?", "options": ["Systemic thrombolysis with weight-based alteplase bolus and infusion", "Urgent catheter-directed thrombolysis with reduced-dose alteplase", "Immediate transfer for surgical embolectomy with cardiopulmonary bypass", "Initiate high-dose unfractionated heparin and defer reperfusion until postpartum", "Administer tenecteplase as a single IV bolus followed by heparin"], "answer": "A", "answer_index": 0, "explanation": "She has high-risk (massive) pulmonary embolism with shock in late pregnancy; systemic thrombolysis is recommended when no absolute contraindications exist, as maternal survival takes priority and pregnancy is only a relative contraindication. Catheter-directed therapy or surgical embolectomy may be considered when thrombolysis is contraindicated or fails, not as first-line; deferring reperfusion is unsafe, and tenecteplase bolus lacks robust pregnancy-specific safety and dosing data compared with standard alteplase protocols.", "generator_model": "gpt-5.1-2025-11-13", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "topics_mapped", "source_label_raw": "obstetrics", "source_quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125", "source_question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251129T045001943Z_gpt-5.1-2025-11-13_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T045001943Z_gpt-5.1-2025-11-13_seed125.jsonl", "pred": "A", "model_outputs": "Let me analyze this case systematically.\n\nClinical Presentation:\n- 28-year-old pregnant woman at 33 weeks gestation\n- Acute dyspnea, pleuritic chest pain, near syncope\n- Hemodynamically unstable: HR 132, BP 82/48 (hypotensive), RR 30, SpO2 89% on 6L O2\n- Echo: Dilated RV, McConnell sign, septal flattening\n\nDiagnosis:\nThis is a high-risk (massive) pulmonary embolism with hemodynamic instability. The echo findings are classic for acute PE with right heart strain.\n\nKey Considerations for Management:\n\n1. Hemodynamic instability - This is the critical factor. BP 82/48 indicates obstructive shock from PE.\n\n2. Pregnancy considerations - While thrombolytics carry bleeding risk (including placental abruption), maternal death from untreated massive PE is the greater immediate threat.\n\n3. Guidelines - For high-risk PE with hemodynamic instability, systemic thrombolysis is indicated even in pregnancy when the maternal life is threatened. The benefit outweighs the risk.\n\nEvaluating Options:\n\n- Option A (Systemic alteplase): Standard treatment for massive PE with hemodynamic compromise. Weight-based dosing is appropriate.\n\n- Option B (Catheter-directed): Takes time to arrange, patient is unstable NOW. Not first-line for hemodynamically unstable patients who need immediate intervention.\n\n- Option C (Surgical embolectomy): Requires transfer, time, and resources. Reserved for when thrombolysis fails or is contraindicated.\n\n- Option D (Heparin alone): Inappropriate for massive PE with shock. Anticoagulation alone won't resolve the acute obstruction fast enough.\n\n- Option E (Tenecteplase): While tenecteplase is used for PE in some settings, alteplase remains the standard FDA-approved agent for PE. Tenecteplase is more commonly used for STEMI.\n\nBest Answer:\nFor a hemodynamically unstable patient with massive PE, systemic thrombolysis is the treatment of choice. Alteplase is the standard thrombolytic for PE. Even in pregnancy, when maternal life is at immediate risk, thrombolysis is indicated.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-007", "question": "A 28-year-old woman presents with recurrent episodes of suddenly \"losing time\" for several hours, during which she is observed by coworkers to function at her high-stress job but later has no recollection of events. She reports chronic depersonalization, multiple unexplained somatic complaints, and a history of severe childhood emotional neglect but denies frank physical or sexual abuse. Neurologic examination and prolonged video EEG are normal, and there is no substance use. She is distressed by the amnesia but also describes the episodes as an \"escape\" from overwhelming emotions. Which of the following psychotherapeutic approaches is most appropriate as a primary treatment strategy at this stage?", "options": ["High-frequency supportive psychodynamic psychotherapy focused on strengthening defenses and minimizing exploration of trauma content", "Trauma-focused exposure therapy directly targeting the amnestic episodes with in vivo and imaginal exposure", "Phase-oriented trauma therapy emphasizing stabilization, skills for affect regulation, and gradual integration of dissociative states", "Manualized cognitive processing therapy focusing on cognitive restructuring of maladaptive trauma-related beliefs without addressing dissociation", "Hypnotic age-regression therapy aimed at recovering repressed memories of early childhood to reduce dissociative barriers"], "answer": "C", "answer_index": 2, "explanation": "This presentation is most consistent with a dissociative disorder; evidence and expert guidelines favor phase-oriented trauma therapy beginning with stabilization and affect regulation before intensive trauma processing. Immediate trauma-focused exposure or memory-recovery approaches (B, E) can worsen dissociation; purely supportive (A) or cognitive-processing (D) strategies without addressing dissociation are insufficient as primary treatment.", "generator_model": "gpt-5.1-2025-11-13", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed129", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed129-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed129.jsonl", "pred": "C", "model_outputs": "This case presents a 28-year-old woman with classic features of a dissociative disorder, likely Dissociative Identity Disorder or Other Specified Dissociative Disorder. Key features include:\n- Recurrent dissociative amnesia with functional behavior during episodes\n- Chronic depersonalization\n- Multiple somatic complaints\n- History of severe childhood emotional neglect\n- Normal neurological exam and EEG (ruling out seizures)\n- No substance use\n\nLet me analyze each option:\n\nA. Supportive psychodynamic therapy focused on strengthening defenses - While supportive approaches have value, this is too limited and doesn't address the core dissociative pathology or provide a pathway toward integration.\n\nB. Trauma-focused exposure therapy directly targeting amnestic episodes - This is contraindicated early in treatment for dissociative disorders. Direct exposure without adequate stabilization can lead to destabilization, flooding, and worsening of symptoms.\n\nC. Phase-oriented trauma therapy emphasizing stabilization, skills for affect regulation, and gradual integration - This is the gold standard for treating dissociative disorders. The three-phase model (stabilization/safety, trauma processing, integration/reconnection) is endorsed by the International Society for the Study of Trauma and Dissociation (ISSTD) guidelines. It prioritizes building coping skills and affect regulation before any trauma work.\n\nD. Cognitive processing therapy without addressing dissociation - CPT is effective for PTSD but not designed for complex dissociative presentations. Ignoring the dissociation would be inadequate treatment.\n\nE. Hypnotic age-regression to recover repressed memories - This is contraindicated and potentially harmful. Memory recovery techniques can create false memories and are not evidence-based treatment.\n\nThe phase-oriented approach is specifically designed for complex trauma and dissociative disorders, starting with stabilization before any trauma processing - which is essential given this patient's current instability.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-008", "question": "A 63-year-old man with long-standing hypertension and ischemic cardiomyopathy (EF 30%) presents with acute right hemiplegia and aphasia 45 minutes after symptom onset. NIHSS is 18. Noncontrast CT head shows no hemorrhage. CT angiography shows left M1 occlusion with favorable collaterals; CT perfusion suggests a large salvageable penumbra. ECG shows sinus rhythm with frequent PVCs. High-sensitivity troponin is mildly elevated and flat on serial testing. You plan IV thrombolysis and urgent mechanical thrombectomy. Which of the following additional acute management steps is most appropriate?", "options": ["Initiate IV unfractionated heparin infusion before mechanical thrombectomy due to high cardioembolic risk", "Administer IV labetalol to reduce blood pressure to <140/90 mm Hg prior to thrombolysis", "Start high-dose statin and delay any antiplatelet therapy until 24 hours after thrombolysis", "Begin dual antiplatelet therapy with aspirin and clopidogrel immediately after thrombolysis", "Place an intra-aortic balloon pump preemptively to support cerebral perfusion during thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "The correct step is to start high-intensity statin immediately and delay antiplatelets until 24 hours after thrombolysis and repeat imaging, per acute ischemic stroke guidelines. Heparin before thrombectomy (A) increases hemorrhagic risk with no proven benefit. Lowering BP below 140/90 (B) before tPA is too aggressive and can worsen cerebral perfusion; only treat if >185/110 to that threshold. Dual antiplatelets immediately after tPA (D) markedly increases hemorrhage risk. Intra-aortic balloon pump (E) has no role in this setting and carries procedural risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "topics_mapped", "source_label_raw": "Neurology", "source_quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "source_question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T045001943Z_gpt-5.1-2025-11-13_seed124.jsonl", "pred": "C", "model_outputs": "Let me analyze this acute stroke case systematically.\n\nPatient Profile:\n- 63-year-old with hypertension, ischemic cardiomyopathy (EF 30%)\n- Acute right hemiplegia and aphasia, 45 minutes from onset\n- NIHSS 18 (severe stroke)\n- CT: No hemorrhage, left M1 occlusion, favorable collaterals, large penumbra\n- Planned: IV thrombolysis + mechanical thrombectomy\n\nAnalyzing each option:\n\nA. IV unfractionated heparin before thrombectomy\n- Anticoagulation before/during acute stroke treatment increases hemorrhagic risk\n- Not standard practice; heparin is contraindicated with thrombolysis\n- Incorrect\n\nB. IV labetalol to reduce BP to <140/90 before thrombolysis\n- For thrombolysis, BP target is <185/110 mmHg (not <140/90)\n- Lowering BP too aggressively can worsen ischemia by reducing collateral flow\n- The target of <140/90 is too aggressive for acute stroke with thrombolysis\n- Incorrect\n\nC. Start high-dose statin and delay antiplatelet therapy until 24 hours after thrombolysis\n- This is CORRECT per guidelines\n- High-intensity statin therapy should be initiated in acute ischemic stroke\n- Antiplatelet therapy (aspirin) should be delayed 24 hours after IV tPA to reduce hemorrhagic transformation risk\n- This is standard of care\n\nD. Dual antiplatelet therapy immediately after thrombolysis\n- Antiplatelet therapy is contraindicated within 24 hours of thrombolysis due to bleeding risk\n- Dual antiplatelet immediately after tPA significantly increases hemorrhage risk\n- Incorrect\n\nE. Intra-aortic balloon pump preemptively\n- IABP is for cardiogenic shock, not stroke management\n- No indication here; patient is in sinus rhythm with stable cardiac status\n- Mildly elevated troponin is flat (not acute MI)\n- Incorrect\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-009", "question": "A 13-year-old girl presents with 1 year of fatigue and exercise intolerance. She has short stature, sensorineural hearing loss, mild ptosis, and a maternal family history of early-onset diabetes and deafness. BMI is 18 kg/m². Random glucose is 230 mg/dL, HbA1c 8.1%. C-peptide is low-normal, and GAD65, IA-2, and ZnT8 antibodies are negative. Lactate is mildly elevated at baseline and rises disproportionately after minimal exercise. Which of the following is the most appropriate initial pharmacologic management of her hyperglycemia?", "options": ["High-dose metformin monotherapy titrated to maximum tolerated dose", "Immediate initiation of a basal-bolus insulin regimen", "Sulfonylurea monotherapy due to likely KATP channel mutation", "GLP-1 receptor agonist therapy to improve insulin secretion", "SGLT2 inhibitor added to lifestyle therapy to decrease renal glucose reabsorption"], "answer": "B", "answer_index": 1, "explanation": "This presentation is most consistent with mitochondrial diabetes (e.g., MIDD) in the context of multisystem mitochondrial disease, for which insulin is preferred due to β-cell failure and risk of lactic acidosis with metformin. Sulfonylureas are indicated in many KATP-channel MODY forms, not mitochondrial disease. GLP-1 agonists and SGLT2 inhibitors are not first-line in pediatric mitochondrial diabetes and have limited safety data in this context.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed128.jsonl", "pred": "B", "model_outputs": "Let me analyze this case systematically.\n\nKey Clinical Features:\n- 13-year-old girl with fatigue and exercise intolerance\n- Short stature, sensorineural hearing loss, mild ptosis\n- Maternal family history of early-onset diabetes and deafness\n- Random glucose 230 mg/dL, HbA1c 8.1%\n- Low-normal C-peptide (some insulin production present)\n- Negative diabetes autoantibodies (GAD65, IA-2, ZnT8)\n- Mildly elevated lactate at baseline that rises disproportionately with exercise\n\nDiagnosis:\nThis presentation is classic for mitochondrial diabetes, specifically likely MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) or MIDD (Maternally Inherited Diabetes and Deafness). The maternal inheritance pattern, sensorineural hearing loss, diabetes, ptosis, short stature, and lactic acidosis with exercise all point to mitochondrial dysfunction.\n\nTreatment Considerations:\n\n- Option A (Metformin): CONTRAINDICATED in mitochondrial disorders because metformin inhibits complex I of the mitochondrial respiratory chain and increases the risk of lactic acidosis, which is already a concern in this patient.\n\n- Option B (Basal-bolus insulin): This is the safest and most appropriate choice for mitochondrial diabetes. Insulin does not interfere with mitochondrial function and effectively manages hyperglycemia.\n\n- Option C (Sulfonylurea): Used for MODY types with KATP channel mutations (like HNF1A-MODY), but this patient's presentation doesn't fit that pattern - she has multisystem involvement suggesting mitochondrial disease.\n\n- Option D (GLP-1 agonist): Not first-line for this type of diabetes; limited data in mitochondrial diabetes.\n\n- Option E (SGLT2 inhibitor): These can increase the risk of ketoacidosis and may worsen metabolic acidosis in someone already prone to lactic acidosis from mitochondrial dysfunction.\n\nGiven the mitochondrial etiology and the need to avoid medications that could worsen lactic acidosis or mitochondrial function, insulin is the safest and most effective choice.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-010", "question": "A 9-year-old boy presents with recurrent episodes of facial flushing, headache, tachycardia, and severe hypertension. Episodes last 20-30 minutes and resolve spontaneously. Between episodes, his blood pressure is mildly elevated. Exam shows café-au-lait macules and multiple cutaneous neurofibromas. Plasma free metanephrines are markedly elevated. MRI abdomen shows a 2.5-cm left adrenal mass and a 1.2-cm right adrenal mass. Genetic testing is pending. Which of the following is the most appropriate next step in management?", "options": ["Unilateral laparoscopic left adrenalectomy to minimize risk of adrenal insufficiency", "Bilateral laparoscopic adrenalectomy with lifelong glucocorticoid and mineralocorticoid replacement", "Begin nonselective beta-blocker therapy, then alpha-blockade after HR control", "Initiate alpha-adrenergic blockade followed by beta-blockade and plan for cortical-sparing adrenal surgery", "Observe with annual imaging because most pediatric pheochromocytomas regress spontaneously"], "answer": "D", "answer_index": 3, "explanation": "This child with NF1 and bilateral adrenal lesions likely has hereditary pheochromocytomas; preoperative management requires alpha-blockade first, then beta-blockade, followed by surgery. In hereditary/bilateral disease, cortical-sparing adrenalectomy is preferred to reduce long-term adrenal insufficiency risk. Beta-blockade before alpha-blockade can precipitate a hypertensive crisis.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-011", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed128.jsonl", "pred": "D", "model_outputs": "Let me analyze this case systematically.\n\nClinical Presentation:\n- 9-year-old boy with episodic symptoms: facial flushing, headache, tachycardia, severe hypertension\n- Episodes last 20-30 minutes (classic for pheochromocytoma)\n- Mildly elevated BP between episodes\n- Physical exam: café-au-lait macules and neurofibromas (suggesting NF1)\n- Markedly elevated plasma free metanephrines\n- Bilateral adrenal masses (2.5 cm left, 1.2 cm right)\n\nDiagnosis:\nThis is bilateral pheochromocytoma in the setting of Neurofibromatosis type 1 (NF1), which is one of the hereditary syndromes associated with pheochromocytoma.\n\nEvaluating Options:\n\nA. Unilateral left adrenalectomy - This ignores the right adrenal mass, which is also likely a pheochromocytoma given the bilateral presentation in a hereditary syndrome.\n\nB. Bilateral adrenalectomy with lifelong replacement - While this addresses both tumors, it commits the patient to lifelong adrenal insufficiency, which carries significant morbidity, especially in a young child.\n\nC. Beta-blocker first, then alpha-blockade - This is WRONG and dangerous. Beta-blockade before alpha-blockade can cause unopposed alpha-adrenergic stimulation leading to hypertensive crisis. Alpha-blockade must always come first.\n\nD. Alpha-blockade first, then beta-blockade, with cortical-sparing surgery - This is correct management:\n1. Proper preoperative preparation with alpha-blockade (phenoxybenzamine) first\n2. Beta-blockade added after adequate alpha-blockade to control reflex tachycardia\n3. Cortical-sparing (partial) adrenalectomy is preferred in hereditary bilateral pheochromocytoma to preserve adrenal function and avoid lifelong steroid dependence\n\nE. Observation - Pheochromocytomas do NOT regress spontaneously and can cause life-threatening hypertensive crises, stroke, or cardiac events. This is incorrect.\n\nBest Answer:\nOption D represents the standard of care: proper medical preparation with alpha-blockade first, followed by beta-blockade, and cortical-sparing surgery to preserve adrenal function in this young patient with hereditary bilateral disease.\n\nThe answer is (D)"}]